Nusano
  • Company
    • Leadership
    • Mission & Values
    • West Valley City
    • Contact Us
  • Technology
  • Batteries
  • Energy
    • HALEU
    • Nuclear Fuel Cycle
  • Industrial
  • Life Sciences
    • Medical Isotopes
    • Request Quote
    • R&D Collaboration
    • Advisory Board
    • About Nuclear Med
  • News
    • Press Releases
    • Video
    • Podcast
    • Email Sign Up
  • Careers
    • Current Openings
    • Life in Utah
Select Page
Nusano to Host Virtual KOL Panel Discussion on December 17, 2024 Previewing the Year Ahead in Radioligand Therapy (RLT)

Nusano to Host Virtual KOL Panel Discussion on December 17, 2024 Previewing the Year Ahead in Radioligand Therapy (RLT)

by Scott Larrivee | Dec 11, 2024 | News

Event replay now available Watch VALENCIA, Calif. – Dec. 11, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced it will host a virtual key opinion leader (KOL) panel discussion on Tuesday, December 17, 2024 at 1:00 PM ET to...
Nusano to Host Radiopharmaceuticals Educational Webinar

Nusano to Host Radiopharmaceuticals Educational Webinar

by Scott Larrivee | Apr 29, 2024 | News

EVENT REPLAY NOW AVAILABLE Recorded June 28, 2024 Nusano and LifeSci Advisors invite you to go back to school… Join us on Friday, June 28, 2024 from 11:30 a.m. to 12:30 p.m. Eastern for Office Hours: Radiopharmaceuticals. This informative discussion will explain...
Nusano to Host December 19 Virtual KOL Event on Emerging Trends in Radiotherapeutics

Nusano to Host December 19 Virtual KOL Event on Emerging Trends in Radiotherapeutics

by Scott Larrivee | Dec 12, 2023 | News

EVENT REPLAY NOW AVAILABLE Recorded December 19, 2023 Press release updated December 14, 2023 to include addition of Dr. Orozco VALENCIA, Calif. – Dec. 12, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it...
Video Replay: Unlocking the Next $20-30B Market Opportunity in Oncology: Radioisotope Production & Applications

Video Replay: Unlocking the Next $20-30B Market Opportunity in Oncology: Radioisotope Production & Applications

by Scott Larrivee | Aug 22, 2023 | News

With many now expecting radiopharmaceuticals to grow into a $20-30 billion market, investors are increasingly looking at the obstacles and opportunities for suppliers and drugmakers in this space. To advance these discussions, on Friday, May 12, 2023, Nusano and...
Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radio-pharmaceuticals

Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radio-pharmaceuticals

by Scott Larrivee | May 4, 2023 | News

Virtual event will take place on Friday, May 12, 2023 at 10 a.m. EST Register NEW YORK – May 4, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it will host a virtual Key Opinion Leader (KOL) event on Friday,...

Recent Posts

  • Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes
  • Talk Radioisotopes: Paul Schrimpf, Proprietor & Entrepreneur, Cyrall
  • Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
  • Nusano CEO Chris Lowe on Connor Group Podcast
  • dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply

Recent Comments

No comments to show.
Nusano
Supplying the fight against cancer & enabling life-changing innovations
  • Follow
  • Follow
  • Follow
Company
about us
Leadership
Contact us
technology

The Nusano Platform
R&D Collaboration

Resources
News
Careers
Suppliers
© 2025 Nusano | Web design
Privacy Policy – Terms of Service